Good post @WBA
You pretty much took the words out of my mouth.
Condoms: FAIL
VivaGel Europe and ROW: FAIL so far
VivaGel USA/FDA: FAIL
DEP with AstraZeneca: Promising but very early (Ph1)
DEP Docetaxel and DEP Portfolio: Promising but unproven and no proof of concept yet.
Viraleze: Me trading some hype but doubtful it will be a COMMERCIAL success.
SPL Market Cap: Plenty of blue sky, success and poor management forgiveness priced in.
Jackie Fairleze: Riding the remuneration gravy train
Hotcopper ramping this week: Overdrive !
Have a great weekend all.
$1.90 Aveaniceweekend, page-6
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
